Lobbying Activity Report

4685-19433

Organization: Incyte Biosciences Canada Corporation
Associated registration: 8900-4685-1
Lobbying Activity date: 2022-06-20
Arranged a meeting: Yes
Posted date: 2022-07-15

In-house lobbyists who participated in the lobbying activity: Cheryl Bielicz Footnote1
Sam Stankovic Footnote1
Senior Public Office Holders who were lobbied in this activity: Mitch Moneo, Assistant Deputy Minister
Pharmaceutical Laboratory & Blood Services, Health
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Discuss innovative agreements for reimbursement and the use of RWE in evaluation of pharmaceutical products.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
Finances and Budgets, Health, Hospitals, Science and Technology, Senior Citizens
Educate government stakeholders about life-science strategies and policies that impact access to innovative medicines.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Economic Development and Trade, Finances and Budgets, Health, Hospitals, Senior Citizens
Educate on the unmet needs of rare cancers and how to facilitate improved processes within the government to allow for innovation in rare diseases.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Hospitals, Science and Technology
Explain the need for expanded Next Generation Sequencing tests in order to provide innovative personalized cancer care to BC patients.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Hospitals, Science and Technology
Identify changes to pharmaceutical legislation supporting appropriate government reimbursement of medicines.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
Health, Hospitals, Science and Technology, Senior Citizens
Raise awareness of the value that innovative medicines provide and demonstrate that Incyte Biosciences Canada supports the growth of the life-science sector in BC.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Economic Development and Trade, Health, Hospitals, Science and Technology
 
Senior officer who filed this Lobbying Activity Report: Christine Lennon
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
 
  1. Footnote1  Indicates new information that was added through a Lobbying Activity Report.

Date Modified: